Director, Global Commercial Strategy, Iza-bren

About the role

As the Director, Global Commercial Strategy for Iza-bren, you will be an integral member of the Global Commercial Strategy (GCS) team, reporting to the VP, Global Commercial Strategy Lead. This role leads the global commercial strategy for key indications of iza-bren (EGFRxHER3 bispecific ADC) and requires close partnership with Clinical Development, Biostatistics, Regulatory, Forecasting/Competitive Intelligence, Market Access, and Medical. You will operate in a fast-paced, ambiguous environment with high expectations for quality and speed, translating clinical and scientific uncertainty into clear commercial perspectives and executive-ready strategic direction.

Responsibilities

• Own commercial asset strategy for assigned iza-bren indication(s), ensuring alignment with the GPT team and broader oncology portfolio strategy.
• Lead development and iterative refinement of Target Product Profiles (TPPs), including designing and pressure-testing market research, gaining TL feedback, and utilizing analogs to validate share/utilization assumptions.
• Lead and continuously refine commercial forecasting, market sizing, and revenue/valuation models; translate clinical, regulatory, or biomarker-inclusion changes into quantified commercial recommendations for cross-functional decision-making.
• Shape and evolve the Clinical Development Plan (CDP) in partnership with Clinical Development, informing indication and study prioritization based on commercial assessment, competitive dynamics, and portfolio trade-offs.
• Develop executive-level governance narratives and materials that translate complex clinical and commercial data into clear, decision-ready recommendations for senior leadership and governance forums.
• Monitor and synthesize the relevant competitive landscape, proactively flagging implications for iza-bren strategy and commercial opportunity.
• Build and maintain excellent stakeholder networks across the GPT, global commercial strategy team, key regional partners, and matrix functions to advance business objectives.
• Represent commercial strategy in the BMS/SystImmune alliance and governance forums, ensuring commercial input is reflected in joint decision-making on trial design, label strategy, and lifecycle planning.

Qualifications

• BS/BA or equivalent required; an MBA or other advanced degree preferred.
• Minimum 6-8 years of pharmaceutical/biotech commercial strategy, marketing, or top-tier consulting experience; oncology experience strongly preferred.
• Experience shaping Clinical Development Plan (CDP) evolution and/or indication prioritization in partnership with Clinical Development.
• Demonstrated end-to-end asset strategy experience in oncology, spanning early development through launch and lifecycle management.
• Experience with global launch sequencing and prioritization across markets and indications.
• Demonstrated experience with pre-launch commercialization: TPP development, market research design, forecasting/valuation, and CIP/CSRE-style planning processes.
• Strong ability to translate complex clinical, scientific, and regulatory data into clear, actionable commercial decisions and recommendations, including comfort making recommendations under uncertainty.
• Proven ability to develop executive-level governance narratives and materials, coupled with strong interpersonal and verbal communication skills.
• Experience representing commercial interests in alliance/partnership governance structures (e.g., joint program/joint steering committees) is a plus.
• Demonstrated success mobilizing cross-functional matrix teams (Clinical, Biostatistics, Regulatory, Market Access, Medical, Forecasting) to drive aligned, timely decisions.
• Well organized, with a demonstrated ability to build a practical workplan, prioritize with autonomy, hold and respect meeting cadences, and manage multiple concurrent workstreams with speed.
• Personal integrity; passionate, energetic, and focused on the company and mission.
• Listens/considers alternative ideas and viewpoints and encourages debate on others' ideas.
• Capacity to grow, develop, and learn from experience.
• Excellent interpersonal and communication skills.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life Benefits:
  • Paid Time Off for US Exempt Employees: Flexible time off (unlimited, with manager approval), 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico, or Rayzebio employees).
  • Paid Time Off for Phoenix, AZ, Puerto Rico, and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
  • Additional time off may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs, and an annual Global Shutdown between Christmas and New Year's Day.

Pay

Princeton - NJ - US: $198,130 - $240,083. The starting compensation range(s) for this role are listed for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee’s work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.

Schedule

BMS has an occupancy structure that determines where an employee is required to conduct their work. This role may be:

• Site-essential: Requires 100% of shifts onsite at your assigned facility.
• Site-by-design: Eligible for a hybrid work model with at least 50% onsite at your assigned facility.
• Field-based or Remote-by-design: Requires the ability to physically travel to visit customers, patients, or business partners and to attend meetings on behalf of BMS as directed.